EMA Consults On Need For Revised Endpoints For Acute Respiratory Distress Syndrome

The European Medicines Agency has identified the need for a number of changes to its 16-year-old guideline on the clinical evaluation of medicinal products for the prevention and treatment of ARDS.

Medical concept. On a human chest x-ray, a pen and strips of paper labeled - Acute respiratory distress syndrome
EU regulatory expectations For ARDS Drugs Are Being Reconsidered • Source: Shutterstock

More from Europe

More from Geography